aTyr Pharma Inc (ATYR) Price Prediction & ForecastATYRaTyr Pharma Inc

Alphio's ATYR stock price prediction model matches the current aTyr Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.02 (+1.50%). The 1-week path is $5.07 (+2.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, aTyr Pharma Inc is not a good buy. The stock is trading at $0.1651, which is significantly lower than its analyst price target of $3.50, indicating potential upside. However, the stock has seen a year-to-date change of -78.25% and a 1-year change of -83.04%, reflecting a severe downtrend. Additionally, the RSI is at 5.767, indicating that the stock is extremely oversold, but this could also suggest a lack of buying interest. The main risk is the company's ongoing financial losses, with a net income of -$10.31 million reported in Q2 2026, which raises concerns about its sustainability and ability to recover.

aTyr Pharma Inc (ATYR) last closed at $4.9499998, losing -7.82%. These facts feed the 1-day and 1-week ATYR price prediction above.